UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

Cancer cell, 2009-06, Vol.15 (6), p.501-513

2009

Volltextzugriff (PDF)

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.7843-7848

2006

Volltextzugriff (PDF)

Therapeutic strategies to target multiple kinases in glioblastoma

Anti-cancer agents in medicinal chemistry, 2011-10, Vol.11 (8), p.700-711

Sathornsumetee, Sith

2011

Volltextzugriff (PDF)

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4722-4729

2007

Volltextzugriff (PDF)

Targeting cancer stem cells through L1CAM suppresses glioma growth

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6043-6048

2008

Volltextzugriff (PDF)

Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma

Biomedicine & pharmacotherapy, 2022-06, Vol.150, p.112979-112979, Article 112979

2022

Volltextzugriff (PDF)

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

Clinical cancer research, 2007-02, Vol.13 (4), p.1253-1259

2007

Volltextzugriff (PDF)

Clinical improvements in temporospatial gait variables after a spinal tap test in individuals with idiopathic normal pressure hydrocephalus

Scientific reports, 2024-01, Vol.14 (1), p.2053-2053, Article 2053

2024

Volltextzugriff (PDF)

Paraneoplastic syndromes

Journal of the neurological sciences, 2021-10, Vol.429, p.118017, Article 118017

Sathornsumetee, Sith

2021

Volltextzugriff (PDF)

Molecularly targeted therapy for malignant glioma

Cancer, 2007-07, Vol.110 (1), p.13-24

2007

Volltextzugriff (PDF)

Twisted tango: brain tumor neurovascular interactions

Nature neuroscience, 2011-11, Vol.14 (11), p.1375-1381

2011

Volltextzugriff (PDF)

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

Journal of clinical oncology, 2008-01, Vol.26 (2), p.271-278

2008

Volltextzugriff (PDF)

Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

Clinical cancer research, 2008-11, Vol.14 (21), p.7068-7073

2008

Volltextzugriff (PDF)

Validity of self-reporting of gait alteration after tap test among patients with idiopathic normal pressure hydrocephalus

Human movement, 2022-01, Vol.23 (1), p.96-104

2022

Volltextzugriff (PDF)

Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy

Nanomaterials (Basel, Switzerland), 2022-07, Vol.12 (15), p.2606

2022

Volltextzugriff (PDF)

Effect of spinal tap test on the performance of sit-to-stand, walking, and turning in patients with idiopathic normal pressure hydrocephalus

Nagoya journal of medical science, 2018-02, Vol.80 (1), p.53-60

2018

Volltextzugriff (PDF)

Antiangiogenic therapy in malignant glioma: promise and challenge

Current pharmaceutical design, 2007-12, Vol.13 (35), p.3545-3558

2007

Volltextzugriff (PDF)

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

Journal of neuro-oncology, 2007-05, Vol.83 (1), p.53-60

2007

Volltextzugriff (PDF)

New approaches to primary brain tumor treatment

Anti-cancer drugs, 2006-10, Vol.17 (9), p.1003-1016

2006

Volltextzugriff (PDF)

SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility

Molecular cancer therapeutics, 2004-06, Vol.3 (6), p.737-745

2004

Volltextzugriff (PDF)

Diagnosis and Treatment of High-Grade Astrocytoma

Neurologic clinics, 2007-11, Vol.25 (4), p.1111-1139

2007

Volltextzugriff (PDF)

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

Clinical cancer research, 2005-11, Vol.11 (22), p.8145-8157

2005

Volltextzugriff (PDF)

Teaching NeuroImages: Erdheim-Chester disease (polyostotic sclerosing histiocytosis)

Neurology, 2015-09, Vol.85 (10), p.e79

2015

Volltextzugriff (PDF)

Teaching Neuro Images : Erdheim-Chester disease (polyostotic sclerosing histiocytosis)

Neurology, 2015-09, Vol.85 (10)

2015

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(83)

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

Therapeutic strategies to target multiple kinases in glioblastoma

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

Targeting cancer stem cells through L1CAM suppresses glioma growth

Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

Clinical improvements in temporospatial gait variables after a spinal tap test in individuals with idiopathic normal pressure hydrocephalus

Paraneoplastic syndromes

Molecularly targeted therapy for malignant glioma

Oligosarcomas, IDH-mutant are distinct and aggressive

Twisted tango: brain tumor neurovascular interactions

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

Validity of self-reporting of gait alteration after tap test among patients with idiopathic normal pressure hydrocephalus

Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy

Effect of spinal tap test on the performance of sit-to-stand, walking, and turning in patients with idiopathic normal pressure hydrocephalus

Antiangiogenic therapy in malignant glioma: promise and challenge

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

New approaches to primary brain tumor treatment

SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility

Diagnosis and Treatment of High-Grade Astrocytoma

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

Teaching NeuroImages: Erdheim-Chester disease (polyostotic sclerosing histiocytosis)

Teaching Neuro Images : Erdheim-Chester disease (polyostotic sclerosing histiocytosis)

Suchergebnisse filtern